← Back to all substances
J

doxycycline

296ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture ...

Known as: doxycycline
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
67,508
Total in FDA
75%
Serious Reports
40
Fatal Outcomes

Seriousness

Serious
377
Non-Serious
123

Sex Distribution

Male
159
Female
320
Unknown
21

Age Distribution

0-17
13
18-40
105
41-64
171
65-84
131
85+
20
Unknown
60

Outcomes

Recovered/Resolved
420
Recovering/Resolving
173
Not Recovered/Not Resolved
237
Recovered with Sequelae
6
Fatal
40
Unknown
699

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-390e9e
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...